Leading Quebec cannabis producer, distributor, and marketer, ROSE LifeScience (ROSE), a Cannabis company based in Huntingdon, has obtained a licence amendment from Health Canada to sell “2.0” cannabis products. This means ROSE can now expand its product range beyond dried flower and pre-rolls, and introduce “2.0” items like edibles, oils, and hashish. “This licence amendment is a game-changer for us,” says ROSE President and CEO Davide Zaffino. “It’s an opportunity to take Quebec’s cannabis industry to the next level by providing consumers with more versatile, more diversified high-quality cannabis products.”
ROSE plans to introduce the new products to Quebec shelves in the next business quarter. “We’re excited to expand our offering and continue to provide Quebecers with local, responsibly-grown products they can trust,” adds Zaffino.
This announcement comes shortly after ROSE celebrated its one-year anniversary of making products available in the Québec market, which is the third-largest cannabis market in the country. (RP)
